Although endogenous and exogenous steroid hormones affect numerous physiologic processes, the interactions of reproductive hormones, chronic exercise training and heat acclimation are unknown. This investigation evaluated the responses and adaptations of 36 inactive females (mean ± SD; age, 21 ± 3y) as they undertook a 7-8 wk program (HAPT) of indoor heat acclimation (90 min·d 36.5°C, 37%rh), administered before and after HAPT, demonstrated that the three subject groups successfully (P<0.05) acclimated to heat (i.e., rectal temperature, heart rate) and improved muscular endurance (i.e., situps, pushups, 4.6-km run time), and body composition characteristics. The stress of HAPT did not disrupt the menstrual cycle length/phase characteristics, ovulation, or plasma hormone concentrations of EU-OV. No between-group differences (P>0.05) existed for rectal and skin temperatures, metabolic, cardiorespiratory, muscular endurance, or body composition variables. A significant difference post-HAPT in the onset temperature of local sweating, ORAL (37.2 ± 0.4°C) versus DEPO (37.7 ± 0.2°C), suggested that steroid hormones influenced this adaptation.
Introduction
During the past two decades, animal and human investigations have clarified the neuroendocrine interactions between the thermoregulatory and reproductive systems.
Specifically in mature rats, estradiol (E 2 ) applied to in vitro tissue slices increased the activity and firing rate of warm-sensitive neurons but not cold-sensitive neurons, harvested from the preoptic area of the anterior hypothalamus (32), whereas progesterone (P 4 ) decreased these responses in warm-sensitive neurons and increased them in cold-sensitive neurons (28). In humans, it is generally recognized that E 2 decreases body temperature by enhancing effector responses (i.e., sudomotor and vasomotor) and heat loss (31).
Conversely, systemic P 4 increases core temperature (6) , suggesting an upward shift in the thermoregulatory set-point (24). These observations agree with the known changes of E 2 , P 4 , and body temperature during the human menstrual cycle. During the early follicular phase, both serum E 2 and P 4 concentrations are low; during the late follicular phase, E 2 is elevated and P 4 is low; and both E 2 and P 4 are high during the mid-luteal phase (12, 23) .
Due to these hormone fluctuations, body temperature during the luteal phase is approximately 0.3 to 0.5°C higher than during the late follicular phase (17, 23, 34) .
Several human studies have utilized oral exogenous hormones to evaluate the effects of ethinyl estradiol (EE) and progestins on exercise performance (9, 26) , thermoregulation in mild (24 -28 °C) (14, 21, 31) and hot (30 -36 °C) (34-36) one reference inserted here environments, exercise responses while wearing impermeable suits at 40°C (37), and resting vasomotor responses while wearing a water-perfused suit heated to 38.5°C (15) . However, little is known about the interactions of exogenous hormones, chronic exercise training and heat acclimation. Therefore, the purpose of the present investigation was to measure the thermal, metabolic, cardiorespiratory, performance, body composition, and perceptual responses and adaptations of healthy young women, as they participated in a 7 -8 wk program (i.e., spanning two menstrual cycles) of heat acclimation and physical training (HAPT). Each woman was voluntarily using either oral contraceptive pills, an injectable steroid contraceptive, or no contraceptive (control).
This research is important and relevant to the unique physiological adaptations and lifestyles of women, in two ways. Firstly, approximately 11.2 million women in the United States, aged 18 -44 y, utilize a pharmacologic contraceptive preparation (13), 28% of all women engage in regular leisure-time physical activities (5) , and outdoor exercise is more common during summer months when ambient temperatures are high. The effects of programs like HAPT on reproductive physiology are unknown. Because the present investigation involved moderate-to-high intensity exercise, we hypothesized that HAPT would not alter menstrual cycle length/phase characteristics, ovulation, or plasma hormone concentrations in the eumenorrheic-ovulatory (control) subjects. Secondly, because the steroid environments of synthetic steroid preparations and the ovarian steroid hormones of the menstrual cycle are markedly different, it is possible that oral estrogen-progestin formulations and injectable depot medroxyprogesterone acetate (MPA) influence heat acclimation and physical training adaptations differently. However, after considering that three days of estrogen supplementation had no effect (i.e., in adult women using no contraception) on heat transfer to the skin or evaporative cooling during exercise (14) , we hypothesized that physiological responses and adaptations would be similar in the three experimental groups throughout HAPT. November and December, in three phases. First, subjects reported to the laboratory for venipuncture within 2 -5 days of the first day of menses to verify the early follicular phase via E 2 and P 4 serum analyses. Samples were then collected every third day until approximately days 9 -11 (dependent on previous menstrual cycle length), and then daily to document the occurrence of an LH surge. In these samples, E 2 , P 4, and LH were assayed. After the documentation of an LH surge, blood samples were collected every third day until the end of the cycle, to document luteal phase characteristics. Subjects who failed to demonstrate an LH surge or who had a luteal phase length less than 10 days and a midluteal P 4 less than 15.9 nmol L -1 , were excluded form the study. These analyses were continued for the duration of the study. Analyses of circulating reproductive hormones were performed at the Department of Fertility and Reproductive Endocrinology, New Britain General Hospital, New Britain, CT.
Methods

Subjects
All subjects voluntarily ingesting oral contraceptives (ORAL group) reported the exact preparation, as shown in Table 1 , and duration of use. All oral preparations contained EE and a second or third generation progestin. These subjects also provided investigators with empty pill packs, at the end of each month, to document therapy details. Compliance to therapy was evaluated by measuring the concentration of plasma EE, prior to training and at the end of training.
[INSERT . The intra-assay and inter-assay coefficients of variation were 8.6% and 9.5%, respectively. The analytical sensitivity of the P 4 assay was 0.3 nmol L . The intra-assay and inter-assay coefficients of variation were 9.3% and 10.4%, respectively. The analytical sensitivity of the PRL assay was 0.5 µg L -1 . The intraassay and inter-assay coefficients of variation were 6.3% and 6.8%, respectively.
Standardization of Testing.
Blood hormone analyses were used to determine the first day of heat acclimation and physical training (HAPT) for EU-OV subjects, such that exercise sessions began during the first week of the follicular phases. All ORAL subjects took pills that contained both oral contraceptives (days 1 -21) and placebo pills (days 22-28). The starting date of HAPT for ORAL was defined as day 1 of the 28-day pill pack, when they began ingesting the estrogen-progestin contraceptive. Thus, the hormone levels for both EU-OV and ORAL were similar (i.e., low) at the beginning of HAPT. The starting date for DEPO was defined as day 1 of an arbitrary 28-day period, as assigned by investigators.
Subjects performed the standardized exercise-heat tolerance test (EHT), before and after HAPT, as follows: EU-OV, on days 2 -5 of the menstrual cycle; ORAL, on days 2 -5 of the placebo phase of the pill pack; DEPO, on days 2 -5 of the arbitrary 28-day period.
Twenty-four to 48 h prior to both EHT, measurements of sweat sensitivity, body composition and VO 2max were conducted. These features of the experimental design ensured that the pre-HAPT and post-HAPT measurements were conducted at the same point relative to reproductive hormones.
Body Composition and VO 2max . Each subject was weighed under water, while suspended from a computer-monitored strain gauge, and on land, to determine body density as described elsewhere (1). From body density values, the percent body fat and the fat-free mass were calculated according to published normative equations (33). On the same day, each subject completed an incremental run on a motorized treadmill to determine VO 2max . This test began at a brisk pace (i.e., based on each individual's previous running experience or estimated time to complete a 5 km run; approximately 75% VO 2max )
for four minutes at 0% grade. The treadmill grade was then increased to 4% for two minutes. At two minute intervals thereafter, the grade was further increased 2% until the subject reached volitional exhaustion. Oxygen uptake, minute ventilation and respiratory exchange ratio were measured every 30 sec, via indirect calorimetry (metabolic cart, model CPX/D, Medical Graphics Corporation, St. Paul, MN). Gas concentrations and flow volume were calibrated to manufacturer specifications prior to each VO 2max test, using certified O 2 -CO 2 gas mixtures and a 3-liter calibration syringe (model R5530, Vacumed, Ventura, CA).
Two of the following criteria verified the attainment of VO 2max : an increase of oxygen consumption less than 150 ml·min -1 despite an increase in work load, or heart rate (Vantage XL heart rate monitor, Polar Electro Inc., Woodbury, NY) greater than 90% of predicted maximum (220 beats·min -1 minus chronologic age), or respiratory exchange ratio (V CO2 /V O2 ) 9 > 1.10. Both the body composition and the VO 2max procedures were repeated at the end of training.
Heat Acclimation/Physical Training Program. After successfully completing screening procedures, subjects participated in 7 -8 wk (i.e., two menstrual cycles) of supervised heat acclimation and physical training (HAPT). HAPT occurred on six days per week, as three outdoor sessions and three indoor sessions, during the months of January and February. Outdoor physical training and indoor heat acclimation activities, in both cold and hot environments, were combined to simulate the variety of stressors encountered by athletes and military personnel.
Outdoor physical training involved strenuous running for 4.6 km at an individualized pace (i.e., exercise intensity estimated at 60 -85%VO 2max ), pushups, and situps; exercise intensity increased weekly as training progressed. During morning running sessions, the mean (+ SD) outdoor air dry bulb and dew point temperatures were -3.9 + 0. and wore a heart rate monitor, to allow rectal temperature (T re ) and heart rate (HR), respectively, to be monitored. If a subject announced that she was unable to continue exercising, she was encouraged to rest in the environmental chamber for the entire 90 min session. However, subjects were removed from the environmental chamber if one of the following predetermined criteria was reached: T re 39.5 °C, HR > 180 beats·min -1 for five consecutive minutes, or signs of exertional heat illness. A trained investigator monitored all training sessions.
Exercise-Heat Tolerance Testing. Subjects performed a standardized exercise-heat tolerance test (EHT) before and after HAPT; both EHT began at the same point relative to the reproductive hormone cycle and at the same time within-day. Water deprivation (24 h) plus mixed aerobic activity (2 -3 h) were utilized to induce dehydration, prior to each EHT.
This dehydration was incorporated to increase the total stress experienced by test subjects.
Body mass (± 50 g; floor scale, model DS44L, Ohaus, Pine Brook, NJ) was measured immediately before and after water restriction plus activity, to ensure the desired 3.0% body mass loss; also, if urine specific gravity (refractometer) did not exceed 1.020, the test was not conducted. Body mass again was measured upon entering, and immediately before leaving, the environmental chamber. These hydration procedures were controlled during both EHT, before and after HAPT.
Once inside the chamber (36.5 ± 1.4 °C, 37 ± 1% rh, 2.3 m·s -1 air flow), subjects stood quietly for 20 minutes, to allow body fluids, plasma volume and skin temperatures to stabilize. After this equilibration, subjects walked on a motorized treadmill at 93. Significance was established at P < 0.05.
Results
Reproductive hormones. Table 2 ). Significantly higher levels of SHBG (P < 0.05; before versus after HAPT) were measured in ORAL (versus EU-OV and DEPO). Although HAPT enhanced physical fitness and induced heat acclimation in all groups (see below), no main effects (between-group or across time; P > 0.05) were observed for E 2 and P 4
concentrations. However, PRL significantly increased during HAPT (P < 0.05) in EU-OV (+33.3%), but not ORAL (+3.4%) or DEPO (+24.3%).
All menstrual cycles of EU-OV, before and after the HAPT intervention, were ovulatory. In EU-OV, menstrual cycle length (before HAPT, 27.1 ± 0.6 d; after HAPT, 28.1 Heat Acclimation. Pre-exercise dehydration level, prior to EHT, was statistically similar across time and between groups (initial EHT, -2.8 ± 0.6%; final EHT, -2.9 ± 0.6% body weight; all groups combined). E 2 and P 4 were similar in all groups, on the morning of EHT tests ( Table 2 ).
The influence of HAPT on resting T re and T sk was evaluated. A significant (P < 0.03, n = 34) main effect of time, with no between-group difference, was detected for pre-exercise T re . The mean (± SD) baseline T re values of all groups combined, measured immediately prior to entering the environmental chamber, were 37.2 ± 0.3°C (before HAPT) and 37.1 ± 0.3°C (after 7 -8 wk of HAPT). The baseline T sk values, measured at the same time as T re ,
were not influenced by HAPT (before, 32.2 ± 0.8°C; after, 32.2 ± 0.9°C).
The following variables indicated that all groups achieved heat acclimation. Total exercise time increased after HAPT by 70.9% (P < 0.05), but no mean differences were detected between treatment groups. Final SR wb was not affected by HAPT (Table 4) VO 2max significantly increased during this investigation. Thus, the mean exercise intensities were 56 ± 5% VO 2max during the initial EHT and 49 ± 5% VO 2max during the final EHT.
These results from EHT (36.5 °C) are shown in Table 4 .
[
INSERT TABLE 4 HERE]
The change of rectal temperature ( T re ) and change of skin temperature ( T sk ) during the EHT were altered by 7 -8 wk of HAPT, but there were no differences between groups in the change of rectal or mean skin temperature. During the initial EHT, mean T re (+1.2 ± 0.4 °C) and T sk (+0.8 ± 0.8 °C) were significantly different (P < 0.005 and P < 0.00001, respectively; n = 34) from the T re (+1.0 ± 0.3 °C) and T sk (-0.3 ± 0.8 °C) measured during the second EHT. [ INSERT TABLE 5 HERE] Diastolic BP rose during the initial EHT (P < 0.0005) and during the final EHT (P < 0.002) in all groups. The grand means for diastolic values were: initial EHT (pre, 73 ± 10 mmHg; post, 63 ± 10 mmHg), second EHT (pre, 72 ± 8 mmHg; post, 65 ± 8 mmHg).
Systolic BP was similar during the initial EHT (baseline versus end of exercise, P > 0.05), but rose during the second EHT (P < 0.0005) in all groups. The grand means ± SD for systolic values were: initial EHT (pre, 103 ± 12 mmHg; post, 108 ± 17 mmHg), second EHT (pre, 101 ± 7 mmHg; post, 115 ± 10 mmHg). No differences due to treatment group or training were detected.
Sweat Sensitivity. Local sweat rate measurements (22.5°C environment) are illustrated in Figure 2 . During HAPT, the sweat onset temperature decreased significantly in ORAL (before HAPT, 37.5 ± 0.2 °C; after HAPT, 37.2 ± 0.4 °C; P < 0.05), but not EU-OV (before HAPT, 37.5 ± 0.2 °C; after HAPT, 37.4 ± 0.2 °C) or DEPO (before HAPT, 37.7 ± 0.1 °C; after HAPT, 37.7 ± 0.2 °C) groups. This resulted in a statistically lower threshold of sweat onset temperature in the ORAL group compared to the DEPO group (post-HAPT; P < 0.05). Sweat sensitivity (i.e. the slope of the linear regression of rectal temperature plotted versus local sweat rate; linear portion of continuous measurements; Figure 2 ) was statistically similar between treatment groups, and was not altered by HAPT.
[INSERT FIGURE 2 HERE]
Discussion
This investigation was designed to evaluate the differential effects of oral and injectable contraceptive therapies on HAPT adaptations during 7 -8 wk of supervised exercise sessions. Consistent with initial hypotheses, (a) the stress of HAPT did not disrupt the menstrual cycle length/phase characteristics, ovulation, or plasma hormone concentrations of EU-OV; and (b) no between-group differences (P>0.05) existed for rectal and skin temperatures, metabolic, cardiorespiratory (baseline, final, delta; during EHT), muscular endurance, or body composition variables. In addition, controlled measurements of fitness, body composition, VO 2max (Table 3) , and exercise-heat tolerance (EHT; Figure 2 , Tables 4 and 5 ) demonstrated that the subjects in all treatment groups exhibited physical fitness and heat acclimation adaptations.
The physiological adaptations to physical training in a cool environment are similar to those experienced in a hot environment, with a few minor exceptions (4, 16) . The nature of HAPT (i.e., which included both physical training in a cool-cold outdoor environment and exercise-heat stress in an environmental chamber) made it difficult to determine which adaptations were stimulated by physical training and which by heat exposure exclusively, but some adaptations may be attributed. For example, specific physical training improved muscular endurance (i.e., situps, pushups), endurance running time, and VO 2max ( Table 3) .
The low-intensity heat exposures of HAPT likely would not have affected these variables, but likely resulted in reduced submaximal VO 2 (i.e., specific to exercise-heat acclimation, not physical training) (3, 4) . A future study, incorporating a longitudinal cross-over design (i.e., the most effective way to separate heat acclimation adaptations from those due solely to physical training [(4)]), would clarify this issue.
As the number of opportunities for women to participate in exercise and sport continues to increase, the number of women involved in exercise and sport programs continues to rise in the United States. As a result of this increased participation in sport by women, the incidence of menstrual cycle disturbances also has increased (10, 18, 30) .
However, our observations of 36 healthy young women, who participated in 7 -8 wk of HAPT, indicated that the menstrual status of the EU-OV group remained unchanged and consequently no abnormalities of reproductive hormone concentrations, and menstrual cycle phase characteristics, were observed.
Blood Analyses. Although plasma volume (PV) typically expands during the initial 5 -10 days of heat acclimation (3), the dynamics of fluid shifts in women (Table 5 ) within the EHT test were not affected by HAPT; this supports previous observations of women, before and after exercise-heat acclimation (cycling exercise, 45°C environment) (20). Similar to PV, plasma glucose concentration was not affected by HAPT (Table 5 ). To our knowledge, no previous study has reported plasma glucose concentration adaptations in women during heat acclimation.
Regarding plasma lactate, a significant main effect (time, P < 0.05) was detected at the end of EHT. Thus, despite exercising in the heat 28.6 min longer during the second controlled test (before HAPT, 77.7 ± 9.2 min; after HAPT, 106.3 ± 41.7 min; all groups combined), at the same absolute treadmill speed, plasma lactate concentration decreased.
This finding likely arose from either the lower relative exercise intensity (i.e., due to an increased VO 2max and improved exercise efficiency subsequent to HAPT), or enhanced lactate clearance (not measured), during the final EHT (7).
Thermal Responses. The ORAL group experienced a decrease of the threshold rectal temperature for the onset of sweating (i.e., within group, NA versus ACCL; see * symbol in Fig. 3 ) as a result of HAPT. This adaptation also was observed in women who completed 60 days of physical training with no contraception therapy (2) . However, similar oral contraceptive preparations (i.e., combined estrogen and progestin) have been shown to increase the sweating threshold of young women, in a manner similar to the endogenous hormones of the luteal phase (15, 21) . Thus, future studies are required to clarify why a significant mean difference of 0.6°C occurred between the threshold temperatures of ORAL and DEPO (Fig. 3 , see ** symbol). Such studies should include women who undertake physical training or heat acclimation programs.
Sweat sensitivity (i.e., the slope of each regression line in Fig.3 ; the ratio of sweat rate / T re ), measured locally over the scapula, was not different between treatment groups, before or after HAPT. This finding is similar to observations published by Charkoudian and Johnson (15) and Grucza et al. (21), which involved the chronic use of female reproductive hormones and changes in the threshold temperatures for effector responses with no change in sweat sensitivity. Further, when estrogen supplementation was administered for only three days, Chang et al. (14) observed no adaptation of either the threshold temperature or the sweat sensitivity. At present, the evidence suggests that sweat sensitivity is not influenced by female reproductive hormones.
Sweat production is controlled by the anterior hypothalamus, which integrates afferent T re and T sk impulses and regulates effector responses, including eccrine sweat gland secretion and skin blood flow (27). Final SR wb did not change as a result of either HAPT or contraceptive type (i.e., both main effects P > 0.05, Table 4 ). This phenomenon was recognized by Henane (22) as one result of the reduced body temperature that occurs with heat acclimation. Because final T re , T re , and T sk decreased during HAPT, the neural drive for sweat production decreased.
Summary. Numerous long-term adaptations occurred during HAPT (i.e., significant main effect of time), in response to HAPT sessions performed by 36 young women. However, the differences of adaptations in ORAL, EU-OV and DEPO were few, 20 small in magnitude, and did not impart superior physical fitness or heat acclimation to any treatment group. Perhaps the most interesting between-group differences involved the threshold temperatures for local sweating. This threshold decreased in ORAL as a result of HAPT (P < 0.05), suggesting that an EE-progestin formulation may lower the hypothalamic set-point; also, the use of depot MPA did not induce a significant change of this threshold during HAPT. Although some pharmacologic agents may alter sweat rate or reduce cardiac contractility during exercise in a hot environment (25) Symbols: *, significant difference (across time, P < 0.05) of sweat onset temperature (ORAL only) due to HAPT; **, significant between-group difference of sweat onset temperature (ORAL < DEPO, P < 0.05) at the post-HAPT time point only. Note: the values in columns 1 and 2 indicate the amount of ethinyl estradiol (EE) or progestin consumed for 21 days, followed by 7 days of placebo pills or no pills. 
120.8 ± 18.0 Table 3 . Physical training and body composition variables (mean ± SD), measured before (NA) and after (ACCL) HAPT. 38.1
All variables, except the 4.6 km outdoor run, were measured in a 22.5°C environment. Symbols: * -significant main effect (across time, P < 0.05) during HAPT. No between-group differences existed for any variable. Abbreviations: NA, not heat acclimated, before HAPT; ACCL, heat acclimated, after HAPT; ORAL, oral contraceptive group; EU-OV, eumenorrheicovulatory group; DEPO, Depo Provera™ group; VO 2max , maximal aerobic power. Table 5 . Plasma variables (mean ± SD) measured during EHT, before and after HAPT.
Plasma Glucose 
